Event Calendar
This is a selection of high-class scientific events on diabetes and cardiovascular risk management in 2006. You may print or download this page to keep it on your desk.

ESC Congress 2008 European Society of Cardiology

Date: 30 August 2008 - 03 September 2008
Location: Munich, Germany
Description: For 2008, the theme of the ESC Congress will be cardiovascular imaging. Over recent years, cardiovascular imaging has become a key component in clinical cardiology.
BSP-Activities: Bayer Schering Pharma will be present with a booth under the motto ‘Connecting Cardiovascular Prevention Strategies’ and a satellite symposium for Cardiovascular Risk Management focusing both on different CV risk factors incl diabetes, its connections and the possible prevention and treatment strategies.

www.escardio.org

WCC 2008 16th World Congress of Cardiology

Date: 18-21 May, 2008
Location: Buenos Aires, Argentina
Description: From patients to population Through the World Congress of Cardiology, the World Heart Federation offers an international stage for the latest developments in science and public outreach in the field of cardiovascular health. The World Congress of Cardiology places emphasis on the complementary nature of science and public outreach and strives to spread the message that through individual, community and patient care interventions, the growing epidemic of cardiovascular disease in developing countries can be prevented--hence, from patients to population.
BSP-Activities: On this congress Bayer Schering Pharma will contribute with a booth and a satellite symposium.presenting its expertise in Cardiovascular Risk Management with latest product data in the field of hypertension, coronary heart disease and diabetes.

www.worldcardiocongress.org

European Society of Cardiology (ESC) Congress 2007

Date: September 1-5, 2007
Location: Vienna, Austria
Description: The ESC Congress was a unique forum where medical professionals could meet their colleagues from all around the world, and exchange ideas and information in the field of cardiovascular medicine. More than 380 scientific sessions in the main areas of clinical interest were presented.
BSP Activities: On this Congress Bayer Schering Pharma was present with two Aspirin Cardio Satellite Symposia and two Joint Telmisartan Satellite Symposia with Boehringer Ingelheim.

Download Programme Joint Satellite ONTARGET
Download Programme Joint Satellite Power
European Society of Cardiology

European Meeting on Hypertension (ESH) 2007

Date: June 15-19, 2007
Location: Milan, Italy
Description: The main scientific programme was held during three days (June 16, 17 and 18, 2007) and consisted of several lectures, Meet-The-Expert Sessions, workshops and Teaching Sessions.
BSP Activities: Bayer Schering Pharma contributed with an Adalat Satellite Symposium. The very interesting Joint Telmisartan Satellite Symposium with Boehringer Ingelheim took place on June 15, 2007; 14:00-17:00.

Download Abstract Book of the Joint Satellite Symposium
offical Website
European Society on Hypertension

Pritor/Kinzal-Exceeding the ARB promise

Date: 23 September 2006
Location: Malta, Italy
Description: The Bayer HealthCare Symposium 'Pritor/Kinzal- Exceeding the ARB promise-' which outlined how Pritor/Kinzal can address the current challenges in hypertension management, delivered a very comprehensive programme to more than 600 physicians from across Europe. The eminent faculty agreed that Pritor/Kinzal not only provides effective and sustained blood pressure control, but has additional cardiometabolic advantages.
Bayer Activities: The symposium dealt with a wide range of topics, including the future of hypertension management, the importance of managing risk factors, reasons for suboptimal blood pressure control, head-to-head comparisons of Pritor/Kinzal with other ARBS and other drug classes and controlling hypertension as part of a multiple-risk-factor management strategy.

Download Meeting Summary
Download Abstract Booklet
Download Meeting Programme
Picture Gallery

World Congress of Cardiology 2006

Date: September 2 - 6, 2006
Location: Barcelona, Spain
Description: The World Congress of Cardiology 2006 brought together the European Society of Cardiology (ESC) Congress 2006 and the World Heart Federation's (WHF) XVth World Congress of Cardiology. This joint meeting, in state-of-the-art facilities, provided high quality scientific content on the latest research in cardiology and prevention and expected to attract well over 25,000 attendees.
Bayer Activities Bayer HealthCare was present on this congress with a satellite symposium on Monday, September 4, 2006, 18:30-20:00, Room Cairo, chaired by Prof. L. Ryden and T. Rabelink. In this satellite, entitled "Where do we stand with cardiovascular risk management? - A debate", Bayer HealthCare highlighted the benefits of its cardiovascular risk products including Glucobay.

Download Programme Satellite Symposium
Further Information

Click here to get to the Patient's section
 
Studies
High blood pressure - an underestimated risk for cardiovascular disease tops the list of causes of death in the Western World
more
 
"Metabolic syndrome and its consequences is a far more serious and real threat to our health than the possibility of avian flu crossing the species barrier from birds to human,"Rhye Williams, Vice President of IDF
modul_02.jpg